BDBekir Enes Demiryurek

Bekir Enes Demiryurek

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Bekir Enes Demiryurek has a total of 42 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Heavy metal accumulation in Parkinson's disease: AN evaluation of hair analysis

    by Bekir Enes Demiryürek, Seda Karayünlü Bozbaş, Onur Gümüş, Songül Şenadım, Riza Sonkaya, Mustafa Ceylan

  • Open Access

    HEAVY METAL ACCUMULATION IN PARKINSON'S DISEASE: AN EVALUATION OF HAIR ANALYSIS

    by Bekir Enes Demiryurek, Seda Karayünlü Bozbaş, Onur Gümüş, Songül Şenadim, Rıza Sonkaya, Mustafa Ceylan

    BackgroundHeavy metals have been implicated in the pathophysiology of Parkinson’s disease (PD) through mechanisms involving oxidative stress, mitochondrial dysfunction, neuroinflammation, and protein aggregation. However, the relationship between metal accumulation and clinical severity remains incompletely understood.ObjectiveThis case–control study investigated hair trace element concentrations and their associations with disease severity in patients with PD.MethodsThirty-one patients with PD and 30 age- and sex-matched healthy controls were enrolled. Hair samples were analyzed using inductively coupled plasma optical emission spectrometry, and concentrations of multiple trace elements were determined. Clinical severity was assessed using the Movement Disorder Society–Unified Parkinson’s Disease Rating Scale Part III (MDS-UPDRS III) and Hoehn and Yahr (H&Y) staging. Disease duration was also recorded.ResultsThere were no significant differences between groups regarding age or sex distribution. Hair aluminum concentrations were significantly lower in patients with PD, whereas zinc, nickel, and lead concentrations were significantly higher compared with controls (all p <0.05). No significant between-group differences were observed for chromium, copper, iron, or manganese. Within the PD group, zinc demonstrated significant inverse correlations with MDS-UPDRS III scores (r = −0.53, p = 0.002), H&Y stage (r = −0.49, p = 0.005), and disease duration (r = −0.50, p = 0.004). No other trace element showed consistent associations with clinical measures.ConclusionsThese findings suggest that zinc dysregulation may accompany disease progression in PD and highlight zinc as a potential biomarker of clinical severity. Further longitudinal studies are needed to clarify the role of zinc homeostasis in Parkinson’s disease.

  • Open Access

    Is there an association between mIDkIne levels and the prognosis of COVID-19 disease?

    by D. Çekiç, S. Yaylacı, H. Dheir, A. C. Genc, İ. Yıldırım, H. Kocayigit, F. B. Tuncer, H. Toptan, E. Çokluk, B. E. Demiryurek, et al.

       The objective was aimed to measure plasma midkine (MK)* levels in patients with COVID-19 and assess its clinical significance.   Materials and Methods. 88 patients observed in our hospital with a diagnosis of COVID-19 were included in the study. The patients’ demographic characteristics, clinical, and laboratory data were studied, and the relationship between MK levels, prognosis, and other parameters was investigated.   Results. Of the 88 patients included in the study, 43 (48.9 %) were female and 45 (51.1%) were male. 24 (27%) patients died. The mean age of non-survivors was 70 ± 12.3 years and the survivors were 61.9 ± 18.2 years. Mortality predictors such as D-dimer, ferritin, troponin, LDH, CRP, and procalcitonin were significantly higher in non-survivors than in survivors (p < 0.05). The median MK level (IR) was 152.5 ± 125 pg/ml in all patients, 143 ± 149 pg/ml in survivors, and 165.5 ± 76 pg/ml in non-survivors (p = 0.546). The difference between these two groups was not statistically significant. The area under the ROC curve was found to be 0.542 (95% CI 0.423–0.661, p = 0.546).   Conclusion. MK is not a biomarker that can replace or reinforce known predictors of mortality in COVID-19 patients.

  • Efficacy of intravenous alpha lipoic acid in the treatment of neuropatic pain due to carpal tunnel syndrome

    by Gülsah Öztürk, Bekir Enes Demiryurek

    In this study, we analyzed the effect of oral and oral + intravenous Alpha-lipoic acid (ALA) treatment on pain level and physical examination findings in patients diagnosed with carpal tunnel syndrome (CTS). A total of 115 patients patricipa­ted in the study. 40 patients were treated with oral ALA after iv. ALA the¬rapy, 35 patients received only oral ALA treatment and 40 patients did not receive any medication.


  • Factors influencing the level of stigma in Parkinson’s disease in western Turkey

    by Esra Demiryurek, Bekir Enes Demiryurek

    Background and purpose – Stigma is a widespread phenomenon in Parkinson’s disease (PD) and has been shown to affect the quality of life of individuals. This study aims to assess the level of stigma and identify the factors contributing to stigma in patients with PD in Turkey. Methods – A total of 142 patients diagnosed with PD between June 2022 and March 2023 were included in the study. Sociodemographic data including age, gender, marital status, education level, and duration of PD were collected using a sociodemographic information form. Motor symptom severity was assessed using the Unified Parkinson’s Disease Rating Scale (UPDRS part III). The disease stage was determined using the Hoehn and Yahr scale. Participants were classified as PIGD (postural instability/gait difficulty) or TD (tremor dominant) based on the UPDRS score. Patients with a UPDRS ratio greater than or equal to 1.5 were classified as TD, while subjects with a ratio less than or equal to 1.0 were classified as PIGD. Ratios between 1.0 and 1.5 were classified as mixed type. Depression was assessed using the Hamilton Depression Rating Scale (HAM-D), while stigma was measured using the Chronic Illness Anticipated Stigma Scale (CIASS) and the stigma sub-scale of the 39-item Parkinson’s Disease Questionnaire (PDQ-39 stigma sub-scale). Results – The mean score on the stigma sub-scale of the PDQ-39 was 7.60±4.39, while the mean total stigma score on the CIASS was 1.37±0.39. Our results indicated that stigma was more prevalent among patients with PD with the TD motor subtype, younger age, shorter disease duration, higher level of disability, and presence of depression symptoms. Conclusion – Our study highlights the association between stigma and disease progression, duration, and depressive symptoms in patients with PD in western Turkey.


  • Open Access

    Role of the optic nerve sheath diameter in the assessment of the effectiveness of decompressive surgery after malignant middle cerebral artery infarction

    by Ozgur Senol, Zeliha Cosgun, Emine Dagistan, Bekir Enes Demiryurek, Seckin Emre Cancan

    Background After a case of stroke, intracranial pressure (ICP) must be measured and monitored, and the gold standard method for that is through an invasive technique using an intraventricular or intraparenchymal device. However, The ICP can also be assessed through a non-invasive method, comprised of the measurement of the optic nerve sheath diameter (ONSD) through ultrasound (US). Objective To evaluate the ICP of patients who underwent wide decompressive craniectomy after middle cerebral artery (MCA) infarction via preoperative and postoperative ONSD measurements. Methods A total of 17 patients, aged between 34 and 70 years, diagnosed with malignant MCA infarction with radiological edema and mid-line shift, who underwent decompressive surgery, were eligible. From the records, we collected data on age, sex, preoperative and postoperative Glasgow Coma Scale (GCS) scores, National Institutes of Health Stroke Scale (NIHSS) score, the degree of disability in the preoperative period and three months postoperatively through the scores on the Modified Rankin Scale (MRS), and the preoperative and postoperative midline shift measured by computed tomography (CT) scans of the brain. Results Preoperatively, the mean GCS score was of 8 (range: 7.7–9.2), whereas it was found to be of 12 (range 10–14) on the first postoperative day (p = 0.001). The mean preoperative NIHSS score was of 21.36 ± 2.70 and, on the first postoperative day, it was of 5.30 ± 0.75 (p < 0.001). As for the midline shift, the mean preoperative value was of 1.33 ± 0.75 cm, and, on the first postoperative day, 0.36 ± 0.40 cm (p < 0.001). And, regarding the ONSD, the mean preoperative measurement was of 5.5 ± 0.1 mm, and, on the first postoperative day, it was of 5 ± 0.9 mm (p < 0.001). Conclusion The ocular US measurement of the ONSD for the preoperative and postoperative monitoring of the ICP seems to be a practical and useful method.


  • Open Access

    A case of bullous pemphigus induced by L-dopa and dopamine agonist

    by Yonca Ünlübaş, Bekir Enes Demiryürek

    Bullous pemphigus (BP) is a chronic autoimmune disease characterized by subepidermal bullae observed in advanced age. Although its etiology is not clearly comprehended, genetic factors, environmental factors, or their associations are to blame. Parkinson’s disease is associated with various dermatological disorders, such as melanoma, seborrheic dermatitis, sweating disorders, BP, and rosacea. In addition, it is reported that L-dopa used in the treatment of Parkinson’s disease also increases the risk of BP. In this study, we aimed to evaluate the relationship between BP and L-dopa and dopamine agonists in our 63-year-old patient, who presented to our clinic with parkinsonism symptoms and initially developed BP after L-dopa treatment, which improved after the drug was discontinued and then reoccurred after the use of dopamine agonists.

  • DEPRESSION AND ANXIETY DISORDERS IN COVID-19 SURVIVORS: ROLE OF INFLAMMATORY PREDICTORS

    by Bekir Enes Demiryürek, Esra Demiryürek, Deniz Çekiç, Kubilay İşSever, Ahmed Cihad Genç, Selcuk Yaylacı

    Infection-triggered perturbation of the immune system, which was observed after previous coronavirus outbreaks, could induce psychiatric sequelae. The spreading of the Coronavirus-19 (COVID-19) pandemic could be associated with psychiatric implications. In this study, we aimed to evaluate the association between inflammatory biomarkers and the levels of depression and anxiety in patients who recovered from COVID-19. We screened 109 COVID-19 survivor adults for psychiatric symptoms on the 15th day of follow-up after discharge from the hospital. The patients were split into two groups, the ones with depression and anxiety, and the ones without depression or anxiety, after the psychiatric interview. Self-rating Beck Depression Inventory (BDI) and Beck Anxiety Inventory (BAI) were applied to assess the levels in patients with depression and anxiety. We collected and recorded the sociodemographic information, clinical data, and baseline inflammatory markers. Higher baseline neutrophil/lymphocyte ratio (NLR) and systemic immune-inflammation index (SII) were found in patients with depression and anxiety. Higher levels of depression and anxiety were found in younger and female patients. Besides, a significant correlation was found between BAI and ferritin levels in patients with anxiety, while no association was found between BAI and other inflammatory biomarkers. Moreover, no significant relationship was found between BDI scores and inflammatory biomarkers in patients with depression. COVID-19 primarily affects the respiratory and cardiovascular systems. Nonetheless, psychiatric involvement is not uncommon and can lead to severe problems if not detected and managed at an early stage. It is recommended that clinicians should be vigilant in terms of psychiatric involvement in COVID-19 patients presenting with high inflammatory parameters.


  • Open Access

    The association between intracranial pressure and optic nerve sheath diameter on patients with head trauma

    by Kaan Çelik, Bekir Enes Demiryurek

    Background: Although intracranial pressure (ICP) monitoring is the gold standard method for measuring intracranial pressure after traumatic brain injury, optic nerve sheath diameter (ONSD) measurement with ultrasound (US) is also used in the evaluation of ICP. Objective: To investigate the association between a series of OSND measurements by US and changes in clinical presentation of the patient. Methods: Prospective study including 162 patients with traumatic brain injury. Age, sex, cerebral CT findings, ONSD levels by US at minutes 0, 60, and 120, Glasgow Coma Scale (GCS) within same period, change of consciousness, treatment, and mortality data were reviewed. The association of ONSD levels with GCS, change of consciousness, treatment, and mortality was evaluated. Results: There was no difference in ONSD changes in the patients’ sample within the period (p=0.326). ONSD significantly increased in patients who died (p<0.001), but not in those who survived (p=0.938). There was no significant change in ONSD of the patients who received anti-edema therapy (p=801), but significantly increased ONSD values were found in those who received anti-edema therapy (p=0.03). Patients without change of consciousness did not have any significant change in ONSD (p=0.672), but ONSD values increased in patients who consciousness became worse, and decreased in those who presented a recovery (respectively, p<0.001, p=0.002). A negative correlation was detected between ONSD values and GSC values measured at primary, secondary, and tertiary time periods (for all p<0.001). Conclusions: ONSD follow-up may be useful to monitor ICP increase in patients with acute traumatic brain injury.


  • Open Access

    Acute cerebellitis accompanied by ataxia: A rare neurological involvement of COVID-19

    by Bekir Enes Demiryürek

    Acute cerebellitis is an inflammatory syndrome characterized by the acute onset of cerebellar signs and symptoms such as ataxia, nystagmus, and dysmetria. Since the start of the coronavirus disease 2019 (COVID-19) pandemic, a significant number of patients with neurological symptoms due to COVID-19 have been reported. In this paper, a 50-year-old male patient diagnosed with acute cerebellitis and ataxia due to COVID-19 infection and who responded to steroid treatment was presented in the light of current literature. Isolated acute cerebellitis and ataxia is a rare manifestation of COVID 19, and since clinically suspected patients respond well to pulse steroid therapy, clinicians should keep this neurological picture in mind.